These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. Swan H, Laitinen P, Kontula K, Toivonen L. J Cardiovasc Electrophysiol; 2005 Feb 28; 16(2):162-6. PubMed ID: 15720454 [Abstract] [Full Text] [Related]
10. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A. Circulation; 2009 May 12; 119(18):2426-34. PubMed ID: 19398665 [Abstract] [Full Text] [Related]
11. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H. Am J Cardiol; 2005 Mar 01; 95(5):700-2. PubMed ID: 15721128 [Abstract] [Full Text] [Related]
19. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child. Duan H, Lu Y, Yan S, Qiao L, Hua Y, Li Y, Zhou K, Wang C. Medicine (Baltimore); 2018 Apr 16; 97(16):e0368. PubMed ID: 29668588 [Abstract] [Full Text] [Related]
20. Complex atrial arrhythmias as first manifestation of catecholaminergic polymorphic ventricular tachycardia: an unusual course in a patient with a new mutation in ryanodine receptor type 2 gene. Lawrenz W, Krogmann ON, Wieczorek M. Cardiol Young; 2014 Aug 16; 24(4):741-4. PubMed ID: 23985380 [Abstract] [Full Text] [Related] Page: [Next] [New Search]